C7orf28B Inhibitors
C7orf28B Inhibitors belongs to a group of compounds specifically designed to modulate the activity of the C7orf28B protein. C7orf28B, also known as Chromosome 7 Open Reading Frame 28B, is a relatively lesser-known protein with limited information available regarding its precise function. However, researchers have identified that inhibiting C7orf28B may have potential implications in regulating certain cellular processes.
Structurally, C7orf28B Inhibitors are designed to interact with the C7orf28B protein, disrupting its normal activity. These inhibitors may function by binding to specific sites on the protein, altering its conformation, or interfering with its interactions with other cellular components. The development and study of C7orf28B Inhibitors contribute to our understanding of the molecular mechanisms associated with this protein. Researchers aim to unravel the biological pathways influenced by C7orf28B and investigate the potential impact of inhibiting its activity on cellular functions. Further studies and experiments are essential to elucidate the exact role of C7orf28B in cellular processes and to evaluate the implications that may arise from modulating its activity using inhibitors.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress the PI3K/AKT/mTOR pathway, which is critical for many cellular processes including protein synthesis and cell survival. Inhibition of this pathway could lead to reduced activity of C7orf28B if it is reliant on mTOR-mediated signaling for its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor which can interrupt the PI3K/AKT pathway. Since PI3K is upstream of mTOR, its inhibition could also indirectly decrease the activity of C7orf28B if it is involved in this signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that acts similarly to Wortmannin, blocking the PI3K/AKT pathway and potentially downregulating C7orf28B activity if it is associated with this pathway. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A CDK4/6 inhibitor which halts cell cycle progression. If C7orf28B function is linked to cell cycle regulation, this compound could indirectly inhibit its activity through cell cycle arrest. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor that prevents the phosphorylation and activation of AKT, diminishing the downstream effects of the PI3K/AKT pathway. By doing so, it could indirectly decrease C7orf28B activity if C7orf28B is a downstream effector in this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that impedes the MAPK/ERK pathway. Inhibition of this pathway could affect C7orf28B if there is cross-talk between the MAPK/ERK signaling and the functional regulation of C7orf28B. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor which can inhibit the JNK signaling pathway. If JNK signaling influences C7orf28B activity, then this inhibitor could lead to a decrease in its functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can disrupt the p38 MAPK pathway. Should C7orf28B activity be modulated by p38 MAPK signaling, this inhibitor could result in reduced C7orf28B function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. If C7orf28B is regulated by this pathway, PD98059 could suppress its activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially impacting C7orf28B if its function is dependent on proteasome-mediated degradation or processing. | ||||||